Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?

被引：4
|
作者：
D'Angelo, Salvatore [1 ]
Secondulfo, Mario [1 ]
De Cristofano, Raffaele [1 ]
Sorrentino, Paolo [1 ]
机构：
[1] SG Moscati Hosp, Liver Unit, I-83100 Avellino, Italy
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2013年 / 19卷 / 14期
关键词：
Entecavir; Hepatocellular carcinoma; Hepatitis B virus; Liver function; Sorafenib; HEPATITIS-B-VIRUS; CIRRHOSIS; EFFICACY; INFECTION; THERAPY; CANCER;
D O I：
10.3748/wjg.v19.i14.2141
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis B virus (HBV) is responsible for 50%-80% of cases of hepatocellular carcinoma (HCC) worldwide. Entecavir (ET) is a potent inhibitor of chronic HBV-DNA polymerase, inhibiting both the priming and elongation steps of viral DNA replication. Sorafenib (SO) has proven efficacy in prolonging survival in patients with advanced HCC. In this frontier report we discuss a possible way to optimize treatment outcomes in patients with HBV and HCC by treatment with ET and SO, on the basis of our practice and published evidence from the literature. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码：2141 / 2143
页数：3
相关论文
共 50 条
  • [1] Sorafenib and entecavir:The dioscuri of treatment for advanced hepatocellular carcinoma?
    Salvatore D’Angelo
    Mario Secondulfo
    Raffaele De Cristofano
    Paolo Sorrentino
    World Journal of Gastroenterology, 2013, (14) : 2141 - 2143
  • [2] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [3] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
    Meyer, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04): : 218 - 220
  • [4] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
    Gauthier, Angela
    Ho, Mitchell
    HEPATOLOGY RESEARCH, 2013, 43 (02) : 147 - 154
  • [5] Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma
    Zheng, Tianying
    Jiang, Hanyu
    Wei, Yi
    Huang, Zixing
    Chen, Jie
    Duan, Ting
    Song, Bin
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (03) : 382 - 394
  • [6] Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma
    Kim, Jeong Eun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Chang, Heung-Moon
    Suh, Dong Jin
    Lee, Han Chu
    Lim, Young-Suk
    Kim, Kang Mo
    Kang, Yoon-Koo
    ONCOLOGY, 2012, 82 (02) : 119 - 125
  • [7] Sorafenib and Radiation Therapy for the Treatment of Advanced Hepatocellular Carcinoma
    Anne M. Horgan
    Laura A. Dawson
    Anand Swaminath
    Jennifer J. Knox
    Journal of Gastrointestinal Cancer, 2012, 43 (2) : 344 - 348
  • [8] Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma
    Tianying Zheng
    Hanyu Jiang
    Yi Wei
    Zixing Huang
    Jie Chen
    Ting Duan
    Bin Song
    Chinese Journal of Cancer Research, 2018, 30 (03) : 382 - 394
  • [9] Safety and Effectiveness of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Prasanthan, Ardra Thottarath
    Raju, Dona
    Vinayakumar, Syamaprasad Thachethukunnil
    Jacob, Mary
    Chandran, Anand
    Vijayan, Meenu
    Keechilatu, Pavithran
    CURRENT CANCER THERAPY REVIEWS, 2022, 18 (02) : 148 - 151
  • [10] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
12345